Ptc Therapeutics (PTCT) Inventory Average (2017 - 2026)

Ptc Therapeutics' Inventory Average history runs 10 years deep, the most recent figure standing at $77.6 million for Q1 2026.

• In Q1 2026, Inventory Average rose 245.93% year-over-year to $77.6 million; the TTM figure through Mar 2026 stood at $77.6 million (up 245.93% YoY), while the FY2025 annual figure was $51.4 million, up 91.26% from the prior year.
• Inventory Average was $77.6 million for Q1 2026 at Ptc Therapeutics, up from $66.2 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $77.6 million in Q1 2026 to a low of $14.9 million in Q3 2022.
• Historically, Inventory Average has averaged $32.1 million across 5 years, with a median of $29.4 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Inventory Average retreated 26.0% in 2025, then soared 245.93% in 2026.
• A 5-year view of Inventory Average shows it stood at $18.3 million in 2022, then surged by 81.13% to $33.2 million in 2023, then retreated by 11.25% to $29.4 million in 2024, then surged by 124.81% to $66.2 million in 2025, then increased by 17.29% to $77.6 million in 2026.
• The last three Inventory Average figures came in at $77.6 million (Q1 2026), $66.2 million (Q4 2025), and $43.4 million (Q3 2025), per Business Quant data.